Prognostic Significance of<i>ASXL1</i>Mutations in Patients With Myelodysplastic Syndromes

Abstract

These results suggest that ASXL1 mutations are frequent molecular aberrations in MDS that predict an adverse prognostic outcome. Screening of patients for ASXL1 mutations might be useful for clinical risk stratification and treatment decisions in the future.